Oct 9, 2026 08:01AM
Oct 9, 2026 08:00AM
Sep 22, 2026 08:00AM
Aug 5, 2026 06:00AM
Jul 9, 2026 06:01AM
Jul 9, 2026 06:00AM
Jun 29, 2026 06:01AM Natera and Aveta Biomics partner on phase 3 head and neck cancer trial
Jun 29, 2026 06:00AM
Jun 23, 2026 03:48PM
Jun 23, 2026 06:01AM
Jun 23, 2026 06:00AM
May 29, 2026 06:03AM
May 29, 2026 06:00AM
May 21, 2026 07:00AM Natera expands Austin operations, plans what it calls world's largest sequencing facility
May 21, 2026 07:00AM
May 15, 2026 12:55PM
May 15, 2026 12:45PM
May 15, 2026 12:32PM
Feb 27, 2026 10:05AM
Feb 2, 2026 06:01AM
Feb 2, 2026 06:00AM Natera Submits Signatera™ CDx PMA to FDA
Nov 6, 2025 04:05PM
Oct 28, 2025 07:01AM
Oct 28, 2025 07:00AM
Oct 20, 2025 01:05AM
Aug 19, 2025 09:22AM
Aug 18, 2025 06:01AM
Aug 18, 2025 06:00AM IMvigor011 Bladder Cancer Trial Achieves Positive Results, with Signatera™ Strongly Predicting Adjuvant Immunotherapy Benefit
Aug 7, 2025 04:05PM
May 8, 2025 04:05PM
Feb 27, 2025 04:05PM
Jan 15, 2025 07:00AM
Dec 2, 2024 08:00AM
Nov 30, 2024 04:00AM
Nov 25, 2024 09:00AM Natera Co-Founder and Executive Chairman Matthew Rabinowitz Named 2024 R&D Leader of the Year
Nov 12, 2024 04:05PM
Aug 8, 2024 04:05PM
May 14, 2024 09:00PM
May 9, 2024 04:05PM
May 1, 2024 07:00AM
Apr 11, 2024 08:00AM
Apr 5, 2024 07:00AM Natera (NTRA) Reports Positive Surveillance Analysis from Phase III IMvigor011 Trial
Apr 5, 2024 07:00AM
Apr 1, 2024 08:07AM
Apr 1, 2024 08:00AM
Mar 14, 2024 08:00AM
Mar 7, 2024 08:06AM
Mar 7, 2024 08:00AM
Feb 28, 2024 04:05PM Natera Reports Fourth Quarter and Full Year 2023 Financial Results
Jan 30, 2024 09:15AM

334,273 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All